Biological therapy practice, biomarkers of severe asthma and novel approaches for attaining immunomodulation in upper airway disease
Clinical & Experimental Allergy · 2023
DOI: 10.1111/cea.14292 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical & Experimental Allergy, 2023. Verfasst von Mohamed H Shamji und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Asthma, Hypersensitivity, Immediate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
The hybrid rDer p 2231 stimulated in PBMCs isolated from atopic patients, higher levels of IL-2, IL-10, IL-15 and IFN-γ, as well as lower levels of IL-4, IL-5, IL-13, TNF-α and GM-CSF. The use of hybrid molecules as a therapeutic model in D. pteronyssinus allergic mice led to the reduction of IgE production and lower eosinophilic peroxidase activity in the airways. We found increased levels of IgG antibodies, which blocked the IgE binding to the parental allergens in serum of atopic patients. Furthermore, the stimulation of splenocytes from mice treated with rDer p 2231 induced higher levels of IL-10 and IFN-γ and decreased the secretion of IL-4 and IL-5, when compared to parental allergens and D. pteronyssinus extract. (7).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Heart and Lung Institute, Imperial College London, London, UK.
- NIHR Imperial Biomedical Research Centre, London, UK.
Zitieren
APA
Shamji, M. H., & Boyle, R. J. (2023). Biological therapy practice, biomarkers of severe asthma and novel approaches for attaining immunomodulation in upper airway disease. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14292
Vancouver
Shamji MH, Boyle RJ. Biological therapy practice, biomarkers of severe asthma and novel approaches for attaining immunomodulation in upper airway disease. Clinical & Experimental Allergy. 2023. doi:10.1111/cea.14292
BibTeX
@article{Shamji2023,
author = {Shamji, Mohamed H and Boyle, Robert J},
title = {Biological therapy practice, biomarkers of severe asthma and novel approaches for attaining immunomodulation in upper airway disease},
journal = {Clinical & Experimental Allergy},
year = {2023},
doi = {10.1111/cea.14292}
}
EUVIMED